[ Price : $8.95]
Federal Register notice: FDA extends the comment period on its proposed rule entitled Labeling Requirements for Approved or Condit...[ Price : $8.95]
Based on disappointing Phase 3 trial data, Otsuka Pharmaceutical terminates its development of the novel compound AVP-786 as a pot...[ Price : $8.95]
FDA asks an advisory panel to vote on the safety and effectiveness of the Guardant Shield colorectal screening test for use with p...[ Price : $8.95]
Federal Register notice: FDA requests that any industry organizations interested in participating in the selection of nonvoting in...[ Price : $8.95]
AdvaMed makes five suggestions to help FDA improve revised Accreditation Scheme for Conformity Assessment guidances.[ Price : $8.95]
FDA medical reviewers share with the Endocrinologic and Metabolic Drugs Advisory Committee their concerns about an increased risk ...[ Price : $8.95]
FDA Oncology Drugs Division director Harpreet Singh leaves the agency to join Precision for Medicine as chief medical officer.[ Price : $8.95]
Public Citizen sues FDA to force it to act on a six-year-old petition seeking labeling changes for SSRIs and SNRIs to highlight th...